Who
Terry L. Evans
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, Fennec Pharmaceuticals.
In numbers
- Trades disclosed
- 23
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 13 Nov 2024
- Last trade
- 12 Oct 2026
- Last filed
- 13 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Oct 2026filed 13 Oct 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | $13K2,326 at $5.53 | filing |
| 30 Sep 2026filed 1 Oct 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —168 at $0.00 | filing |
| 31 Aug 2026filed 31 Aug 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —168 at $0.00 | filing |
| 31 Aug 2026filed 31 Aug 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —168 at $0.00 | filing |
| 31 Jul 2026filed 3 Aug 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —168 at $0.00 | filing |
| 31 Jul 2026filed 3 Aug 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —168 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —168 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —168 at $0.00 | filing |
| 31 May 2026filed 1 Jun 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —168 at $0.00 | filing |
| 31 May 2026filed 1 Jun 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —168 at $0.00 | filing |
| 30 Apr 2026filed 1 May 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —168 at $0.00 | filing |
| 30 Apr 2026filed 1 May 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —168 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —18,456 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —171 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | FENC Fennec Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $692K120,000 at $5.77 | filing |
| 31 Mar 2026filed 2 Apr 2026 | FENC Fennec Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $692K120,000 at $5.77 | filing |
| 31 Mar 2026filed 2 Apr 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —18,456 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —171 at $0.00 | filing |
| 28 Mar 2026filed 2 Apr 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —2,052 at $0.00 | filing |
| 28 Mar 2026filed 2 Apr 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —2,052 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.